Population-based cancer survival is a key metric in evaluating the effectiveness of national cancer control policies and interventions. The “Healthy China 2030 Planning Outline” has set a goal to increase the overall cancer survival rate in China by 15%. Accurate collection of population-based cancer follow-up data is a key step in assessing progress in cancer prevention and treatment across various regions in China.
Multi-source data linkage enhances reliability of population-based cancer survival estimates
